Add Trial
Sign In

TAHOE / M16-289 - Hosted By


Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy

Study Type Interventional (Clinical Trial)
Sponsor Name Abbvie
Disease type Small Cell Lung Cancer
Disease Stage IV
Clinical Status Second Line
Phase III
Intervention / Treatment Rovalpituzumab Teserine / Topotecan
Research Site Sacré Coeur
Investigator Dr Kevin Jao
Coordinator Anne-Marie Laliberté
Telephone number
Fax number
Study start date 23-Feb-17
Study end date
Trial Status Recruiting
Study Type Treatment, Clinical Research
Sponsor Name
Tumor Site Small Cell Lung Cancer
Disease Stage Stage IV
Clinical Status
Phase Phase I
Intervention / Treatment
Research Site Montreal, QC
Telephone Number 514-338-2222 ext 2818
Fax Number
Study Start Date
Study End Date
Trial Status


Working Hours :

Now Closed UTC - 4
  • MondayDay Off
  • TuesdayDay Off
  • WednesdayDay Off
  • ThursdayDay Off
  • FridayDay Off
  • SaturdayDay Off
  • SundayDay Off

Price / Claim :

Recruit a patient:

*for confidentiality, do not include the name of the patient

*pour raisons de confidentialit, n'incluez pas le nom du patient

Hosted by :

More from this author :

Claim listing: TAHOE / M16-289

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Reply to Message


Account details will be confirmed via email.

Reset Your Password